CLOZAPINE FOR TARDIVE-DYSKINESIA IN ADOLESCENTS

被引：23
|
作者：
LEVKOVITCH, Y
KRONENBERG, J
KAYSER, N
ZVYAGELSKI, M
GAONI, B
GADOTH, N
机构：
[1] BEILINSON MED CTR,DEPT NEUROL,IL-49100 PETAH TIQWA,ISRAEL
[2] TEL AVIV UNIV,SACKLER FAC MED,SHALVATA MENTAL HLTH CTR,IL-69978 TEL AVIV,ISRAEL
来源：
BRAIN & DEVELOPMENT | 1995年 / 17卷 / 03期
关键词：
TARDIVE DYSKINESIA; CLOZAPINE; ADOLESCENCE; NEUROLEPTIC;
D O I：
10.1016/0387-7604(95)00034-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Thousands of adolescents use neuroleptic drugs over extended periods of time for a wide range of mental disorders. One of the most severe adverse effects of neuroleptic drugs is tardive dyskinesia (TD), for which no successful treatment is currently available. Clozapine is a known atypical neuroleptic drug with few extrapyramidal side effects. It has been suggested that clozapine may be beneficial for the treatment of tardive dyskinesia in adolescents. However, the efficacy of the drug in adolescents is unknown. This report describes the beneficial effect of clozapine on tardive dyskinesia in two adolescents with schizophrenia.
引用
收藏
页码：213 / 215
页数：3
相关论文
共 50 条
  • [1] CLOZAPINE AND TARDIVE-DYSKINESIA
    SINGER, JM
    ARCHIVES OF GENERAL PSYCHIATRY, 1983, 40 (03) : 347 - 347
  • [2] CLOZAPINE IN TARDIVE-DYSKINESIA
    SIMPSON, GM
    LEE, JH
    SHRIVASTAVA, RK
    PSYCHOPHARMACOLOGY, 1978, 56 (01) : 75 - 80
  • [3] CLOZAPINE EFFECTS ON TARDIVE-DYSKINESIA
    LIEBERMAN, JA
    SALTZ, BL
    JOHNS, CA
    POLLACK, S
    KANE, JM
    PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (01) : 57 - 62
  • [4] CLOZAPINE PHARMACOLOGY AND TARDIVE-DYSKINESIA
    LIEBERMAN, J
    JOHNS, C
    COOPER, T
    POLLACK, S
    KANE, J
    PSYCHOPHARMACOLOGY, 1989, 99 : S54 - S59
  • [5] THE EFFECTS OF CLOZAPINE ON TARDIVE-DYSKINESIA
    LIEBERMAN, JA
    SALTZ, BL
    JOHNS, CA
    POLLACK, S
    BORENSTEIN, M
    KANE, J
    BRITISH JOURNAL OF PSYCHIATRY, 1991, 158 : 503 - 510
  • [6] DOES CLOZAPINE CAUSE TARDIVE-DYSKINESIA
    KANE, JM
    WOERNER, MG
    POLLACK, S
    SAFFERMAN, AZ
    LIEBERMAN, JA
    JOURNAL OF CLINICAL PSYCHIATRY, 1993, 54 (09) : 327 - 330
  • [7] CLOZAPINE AND TARDIVE-DYSKINESIA - PROSPECTIVE DATA
    KANE, JM
    LIEBERMAN, J
    POLLACK, S
    SAFFERMAN, A
    SCHIZOPHRENIA RESEARCH, 1991, 4 (03) : 364 - 365
  • [8] CLOZAPINE-RELATED TARDIVE-DYSKINESIA
    DAVE, M
    BIOLOGICAL PSYCHIATRY, 1994, 35 (11) : 886 - 887
  • [9] THE PREVALENCE OF AKATHISIA AND TARDIVE-DYSKINESIA IN PATIENTS ON CLOZAPINE
    CHENGAPPA, KNR
    SHELTON, MD
    BAKER, RW
    SCHOOLER, NR
    BAIRD, J
    DELANEY, J
    BIOLOGICAL PSYCHIATRY, 1993, 33 (6A) : A126 - A126
  • [10] HIGH PLASMA CLOZAPINE LEVELS IN TARDIVE-DYSKINESIA
    POLLACK, S
    LIEBERMAN, J
    KLEINER, D
    SZYMANSKI, S
    KANE, J
    BORENSTEIN, M
    COOPER, T
    PSYCHOPHARMACOLOGY BULLETIN, 1993, 29 (02) : 257 - 262
12345